🇺🇸 FDA
Patent

US 10143671

Solid solution compositions and use in chronic inflammation

granted A61KA61K31/12A61K31/121

Quick answer

US patent 10143671 (Solid solution compositions and use in chronic inflammation) held by Infirst Healthcare Limited expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infirst Healthcare Limited
Grant date
Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/12, A61K31/121, A61K31/192, A61K31/196